Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Control Bionics Ltd. ( (AU:CBL) ) has shared an update.
Control Bionics Limited has lodged a notice with the ASX for a proposed issue of up to 8,443,747 new fully paid ordinary shares. The securities are to be issued via a placement or other type of issue on 31 December 2025, indicating the company is seeking to raise additional equity capital, which may support its ongoing operations or strategic initiatives and result in dilution for existing shareholders depending on the final pricing and allocation.
The most recent analyst rating on (AU:CBL) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Control Bionics Ltd. stock, see the AU:CBL Stock Forecast page.
More about Control Bionics Ltd.
Average Trading Volume: 1,161,344
Technical Sentiment Signal: Buy
Current Market Cap: A$26.23M
Learn more about CBL stock on TipRanks’ Stock Analysis page.